Tracheitis overview: Difference between revisions
| Line 18: | Line 18: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
Treatment of [[tracheitis]] involves prompt intiation of [[Antibiotic|antibiotics]] and clinical assessment of [[airway]]. Signs of impending [[respiratory failure]] include i[[Intercostal|ntercostal]] [[Retraction|retractions]], [[Cyanosis|cyanosis,]] [[lethargy]] and [[confusion]]. [[Endotracheal intubation]] is performed in impending [[respiratory failure]] to maintain airway, perform frequent [[pulmonary toilet]] and manage acute [[respiratory failure]]. Operative [[bronchoscopy]] can be performed for direct visualisation of [[trachea]], confirmation of the diagnosis and removal of [[pseudomembranes.]] [[Endotracheal intubation]] rate has been reported between 38% to 100% and the mean duration of [[intubation]] is 3.2 days. It is therefore a crucial part of management of [[tracheitis]] which requires judicious assessment of the [[airway]] patency and the urgent availability of skills and expertise required for immediate [[airway intubation]]. Empiric broad spectrum [[Antibiotic|antibiotics]] are initially used to control the [[Infection|infection.]] As the [[Trachea|tracheal]] [[Culture medium|culture]] result becomes available the [[Antibiotic|antibiotics]] can be changed according to the [[organism]] isolated. Most commonly isolated [[Organism|organisms]] include [[Staphylococcus aureus|Staphylococcus Aureus]], [[Streptococcus Penumoniae Infection|Streptococcus Pneumonia]] and [[Moraxella catarrhalis|Moraxella Catarrhalis]]. [[Cephalosporins|Third generation cephalosporin]] combined with an anti staphylococcal [[antibiotic]] e.g [[Nafcillin]], [[Vancomycin]] , [[Clindamycin]] are included in the initial [[antibiotic]] regimen. Current guidelines have outlined a total treatment duration of 10 to 14 days. | |||
Supportive respiratory care is provided in less severe clinical presentation. This includes supplemental [[oxygen]] ( Sp02=94%)and [[bronchodilators]] ([[Epinephrine (patient information)|Epinephrine]] or [[Albuterol]]). [[Anti-pyretics]] can be used for [[Fever|fever.]] [[Corticosteroids]] have not proven benefit but are still used nonetheless. | |||
==References== | ==References== | ||
Revision as of 15:50, 1 July 2020
|
Tracheitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tracheitis overview On the Web |
|
American Roentgen Ray Society Images of Tracheitis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tracheitis is a bacterial infection of the trachea and is capable of producing airway obstruction.
Causes
Tracheitis is most often caused by the bacteria Staphylococcus aureus. It frequently follows a recent viral upper respiratory infection. Common causes include Streptococcus Pyogenes, Haemophilus Influenza, Moraxella Catarrhalis, Mycoplasma Pneumonia, Echoviruses, Klebsiella Pneumonia, Adenovirus, Rhinovirus, Coxsakievirus and Influenza virus.
Risk Factors
Common risk factors in the development of tracheitis include pediatric age group, viral upper respiratory tract infection, mechanical ventilation and immunocompromised state. The individuals most likely to be affected are between 2-10 years of age. Staphylococcus Aureus is the most commonly cultured organism on tracheal aspirate. Mechanical ventilation allows easy colonization of the trachea by bacteria and cause tracheitis. Invasive fungal infections commonly develop among immunocompromised individuals and can cause tracheitis.
Diagnosis
Physical Examination
The muscles between the ribs may pull in as the child tries to breathe.
Treatment
Medical Therapy
Treatment of tracheitis involves prompt intiation of antibiotics and clinical assessment of airway. Signs of impending respiratory failure include intercostal retractions, cyanosis, lethargy and confusion. Endotracheal intubation is performed in impending respiratory failure to maintain airway, perform frequent pulmonary toilet and manage acute respiratory failure. Operative bronchoscopy can be performed for direct visualisation of trachea, confirmation of the diagnosis and removal of pseudomembranes. Endotracheal intubation rate has been reported between 38% to 100% and the mean duration of intubation is 3.2 days. It is therefore a crucial part of management of tracheitis which requires judicious assessment of the airway patency and the urgent availability of skills and expertise required for immediate airway intubation. Empiric broad spectrum antibiotics are initially used to control the infection. As the tracheal culture result becomes available the antibiotics can be changed according to the organism isolated. Most commonly isolated organisms include Staphylococcus Aureus, Streptococcus Pneumonia and Moraxella Catarrhalis. Third generation cephalosporin combined with an anti staphylococcal antibiotic e.g Nafcillin, Vancomycin , Clindamycin are included in the initial antibiotic regimen. Current guidelines have outlined a total treatment duration of 10 to 14 days. Supportive respiratory care is provided in less severe clinical presentation. This includes supplemental oxygen ( Sp02=94%)and bronchodilators (Epinephrine or Albuterol). Anti-pyretics can be used for fever. Corticosteroids have not proven benefit but are still used nonetheless.